Akari enrols seven out of nine patients in bullous pemphigoid trial
Akari Therapeutics’ Phase II trial investigating Coversin (nomacopan) in mild-to-moderate bullous pemphigoid has so far enrolled seven out of its...
Trending menu:
-
![Cassiopea’s Winlevi uptake in acne driven by new mechanism though interest to wane]()
Cassiopea’s Winlevi uptake in acne driven by new mechanism though interest to wane
-
![AstraZeneca’s Imfinzi falls at another hurdle in non-small cell lung cancer trial]()
AstraZeneca’s Imfinzi falls at another hurdle in non-small cell lung cancer trial
-
![The most researched drugs in cystic fibrosis trials]()
The most researched drugs in cystic fibrosis trials
-
![Improved clinical efficacy found wanting in Phase III IMPALA trial]()
Improved clinical efficacy found wanting in Phase III IMPALA trial
-
![New, efficacious options offer hope for Ebola treatment and containment]()
New, efficacious options offer hope for Ebola treatment and containment
-
![GSK’s Zejula meets primary goal in Phase III ovarian cancer trial]()
GSK’s Zejula meets primary goal in Phase III ovarian cancer trial
Expert commentary & analysis from GlobalData
First-in-class HIF-2a inhibitor could revolutionise renal cell carcinoma treatment algorithm
Trial halted early as Nuplazid shows strong efficacy in dementia-related psychosis
Stivarga’s potential in combination therapy for metastatic colorectal cancer
Novartis still hoping for Entresto success in heart failure with preserved ejection fraction
Most Read
Company releases
Pharmaceutical Drug Development and Particle Sizing
Typically, when an individual is suffering from minor ailments at home, such as a headache, heartburn or a common cold,...
Sometimes, You Have to Move to Go Forward
Inocure at Electrospin, China
Inocure presented at the 6th International Conference on Electrospinning in China.
See Malvern Panalytical’s Upcoming Webinars
Pfanstiehl to Attend Two Events in August
Pfanstiehl has announced that it will be sponsoring the 2019 Colorado Protein Stability Conference.
Company whitepapers
Study: Comparing Efficacy and Tolerability of New Daily Oral Vitamin B12 and Intermittent Intramuscular Vitamin B12
Emisphere TechnologiesPrimary Cells Isolated from Healthy Human and Animal Tissues
Caltag MedsystemsSTZ-Induced Rat Model of Diabetes
Noble Life SciencesUnderstanding Sucrose: Matching Sucrose Quality to Functional Need
PfanstiehlClinical Trials: Gene Therapy
GlobalDataClinical Trials: A Round-Up of 2018
GlobalDataProtein Sciences Platform
NEOMED-LABSCompany A-Z
Clinical Trials
Study finds Janssen’s ponesimod superior to Sanofi’s Aubagio
Johnson & Johnson unit Janssen Pharmaceutical has reported positive data from the Phase III OPTIMUM trial, where its ponesimod demonstrated superior efficacy compared to Sanofi’s...
Signant Health to assist Shanghai Mental Health Center in trial
Tocagen’s cancer drug fails to improve survival in glioma trial
Moderna reports positive data for CMV vaccine in Phase I trial
NIA to fund initiative to test new dementia care interventions
Drug Development
Study finds Janssen’s ponesimod superior to Sanofi’s Aubagio
Johnson & Johnson unit Janssen Pharmaceutical has reported positive data from the Phase III OPTIMUM trial, where its ponesimod demonstrated superior efficacy compared to Sanofi’s...
Biogen finds long-term use of Tecfidera is safe and effective in MS
Lilly’s selpercatinib shows positive response in NSCLC patients
Retrophin’s fosmetpantotenate fails in Phase III trial for PKAN
ViiV’s long-acting HIV regimen passes late-stage trial
Go Top